CONTENT CONTINUES BELOW
Tested on people with prostate cancer, the technique increases the chances of earlier diagnosis.
Canada has already approved the treatments which can slow progression of HER2-positive breast cancer.
The breast screening guidelines from the Canadian Task Force on Preventive Health Care, which included no breast cancer experts, were largely based on a flawed study.
The little ribbon that appears on products and services is not regulated or protected. The promises companies make about donations to fighting cancer may very well be empty.
A new study has identified flaws in data used to develop breast screening criteria, a mistake that experts say may have caused the deaths of more than 400 Canadian women annually.
CONTENT CONTINUES BELOW
CONTENT CONTINUES BELOW
